# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060395
Filing Date
2024-05-15
Accepted
2024-05-15 16:00:50
Documents
49
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pstv-20240331.htm iXBRL | 10-Q | 1232996
2 | EX-31.1 | pstv-ex31_1.htm | EX-31.1 | 13770
3 | EX-31.2 | pstv-ex31_2.htm | EX-31.2 | 11069
4 | EX-32.1 | pstv-ex32_1.htm | EX-32.1 | 13308
| Complete submission text file | 0000950170-24-060395.txt |  | 5144679

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pstv-20240331.xsd | EX-101.SCH | 1000957
53 | EXTRACTED XBRL INSTANCE DOCUMENT | pstv-20240331_htm.xml | XML | 494462

Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 24950080
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)